Job from partner
Send messageDescription of the job
Job Description
This group sees over 3,000 new oncology consults annually and cares for patients at the Brampton Civic Hospital and Etobicoke General Hospital, with a satellite site for systemic therapy delivery at Headwaters Health Care Centre. Our division is separated by medical oncology solid tumours and hematology with an associated Division lead for Medical Oncology and Hematology. There are numerous unique opportunities for Hematologists at Osler including a robust research program, engaging in numerous phase II/III clinical trials and investigator-initiated research. There are opportunities for quality improvement projects, medical education in which some clinicians have University appointments.
Remuneration is fee-for-service as set by the OHIP Schedule of Benefits for benign hematology and Fees including AFP for malignant hematology.
About the Program
Our benign hematology out-patient clinics at Brampton Civic Hospital and Etobicoke General Hospital are supported by clinic nurses, clerical, and a pharmacist, in addition the clinic is supported for transfusions. The program is supported by a dedicated RBC disorder/sickle cell clinic with NP support. The oncology program consists of 16 Oncologists & Hematologists and is supported by a team-based model of care with dedicated team-based nursing, clerical, pharmacy and allied health. The program has a General Practitioner in Oncology supported hematology clinic, a nurse practitioner led urgent care clinic, hospitalist supported inpatient oncology unit, in addition to proactive monitoring of patients on systemic therapy through our Oral Anti-Cancer Chemotherapy Program and Osler Cancer Immunotherapy Program. We do offer some local complex hematology care with a day 1 autologous stem cell transplant transfer program in connection with Princess Margaret Cancer Centre, in addition we have been providing Bispecific T Cell Engagers since September of 2023. We have a strong collaboration with our palliative care team with Osler being the first community Oncology program in Canada that has the ESMO designation of integrated oncology & palliative care program. We are leaders in molecular testing and currently offer in house rapid next generation sequencing, including funding for myeloproliferative disorders.
